LLY

732.88

+0.07%↑

JNJ

177.5

+0.27%↑

ABBV

211.68

+0.66%↑

UNH

308.79

-0.21%↓

NVO

56.36

-0.23%↓

LLY

732.88

+0.07%↑

JNJ

177.5

+0.27%↑

ABBV

211.68

+0.66%↑

UNH

308.79

-0.21%↓

NVO

56.36

-0.23%↓

LLY

732.88

+0.07%↑

JNJ

177.5

+0.27%↑

ABBV

211.68

+0.66%↑

UNH

308.79

-0.21%↓

NVO

56.36

-0.23%↓

LLY

732.88

+0.07%↑

JNJ

177.5

+0.27%↑

ABBV

211.68

+0.66%↑

UNH

308.79

-0.21%↓

NVO

56.36

-0.23%↓

LLY

732.88

+0.07%↑

JNJ

177.5

+0.27%↑

ABBV

211.68

+0.66%↑

UNH

308.79

-0.21%↓

NVO

56.36

-0.23%↓

Search

Stryker Corp

Suletud

SektorTervishoid

389.64 -0.43

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

385.47

Max

391.32

Põhinäitajad

By Trading Economics

Sissetulek

884M

1.5B

Müük

156M

6B

P/E

Sektori keskmine

51.842

35.733

Aktsiakasum

3.13

Dividenditootlus

0.85

Kasumimarginaal

25.54

Töötajad

53,000

EBITDA

634M

1.5B

Soovitused

By TipRanks

Soovitused

Tugev "osta" hinnang

12 kuu keskmine prognoos

+11.33% upside

Dividendid

By Dow Jones

Dividenditootlus

Sektori keskmine

0.85%

3.13%

Järgmine tulemuste avaldamine

28. okt 2025

Järgmine dividendimakse kuupäev

31. okt 2025

Järgmine aktsia dividendi kuupäev (ex-date)

30. sept 2025

Turustatistika

By TradingEconomics

Turukapital

-3.5B

150B

Eelmine avamishind

390.07

Eelmine sulgemishind

389.64

Uudiste sentiment

By Acuity

35%

65%

111 / 371 Pingereas Healthcare

Tehniline skoor

By Trading Central

Kindlus

Weak Bullish Evidence

Stryker Corp Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

31. juuli 2025, 20:42 UTC

Tulu

Stryker Lifts Guidance on Improving Tariff Outlook

1. mai 2025, 20:56 UTC

Tulu

Stryker Lowers Adjusted EPS View on $200 Million Tariff Impact

28. jaan 2025, 21:55 UTC

Tulu

Stryker Sees Further Organic Sales Growth in 2025

28. jaan 2025, 21:46 UTC

Omandamised, ülevõtmised, äriostud

Stryker to Sell Spinal Implants Business to Viscogliosi Brothers

31. juuli 2025, 20:09 UTC

Tulu

Stryker Estimates Net Impact From Tariffs in 2025 of Approximately $175M

31. juuli 2025, 20:09 UTC

Tulu

Stryker Sales >SYK

31. juuli 2025, 20:09 UTC

Tulu

Stryker Sees FY25 Organic Net Sales Up 9.5%-10%

31. juuli 2025, 20:05 UTC

Tulu

Stryker 2Q Sales $6B >SYK

31. juuli 2025, 20:05 UTC

Tulu

Stryker 2Q Net $884M >SYK

31. juuli 2025, 20:05 UTC

Tulu

Stryker Sees FY Adj EPS $13.40-Adj EPS $13.60 >SYK

31. juuli 2025, 20:05 UTC

Tulu

Stryker 2Q EPS $2.29 >SYK

31. juuli 2025, 20:05 UTC

Tulu

Stryker 2Q Adj EPS $3.13 >SYK

31. juuli 2025, 20:05 UTC

Tulu

Stryker 2Q Sales $6B >SYK

31. juuli 2025, 20:05 UTC

Tulu

Stryker 2Q EPS $2.29 >SYK

31. juuli 2025, 20:05 UTC

Tulu

Stryker 2Q EPS $2.29 >SYK

1. mai 2025, 20:41 UTC

Tulu

Stryker Lowers Adjusted EPS View on $200M Tariff Impact

1. mai 2025, 20:11 UTC

Tulu

Stryker Cuts FY25 View To Adj EPS $13.20-Adj EPS $13.45 >SYK

1. mai 2025, 20:10 UTC

Tulu

Stryker Raising FY25 Organic Net Sales Growth Guidance Range to 8.5% to 9.5% >SYK

1. mai 2025, 20:05 UTC

Tulu

Stryker 1Q Adj EPS $2.84 >SYK

1. mai 2025, 20:05 UTC

Tulu

Stryker 1Q Net $654M >SYK

1. mai 2025, 20:05 UTC

Tulu

Stryker 1Q EPS $1.69 >SYK

1. mai 2025, 20:05 UTC

Tulu

Stryker 1Q Sales $5.87B >SYK

1. mai 2025, 20:05 UTC

Tulu

Stryker 1Q EPS $1.69 >SYK

19. veebr 2025, 13:53 UTC

Omandamised, ülevõtmised, äriostud

Stryker Files 8K - Asset Acquisition Or Disposition >SYK

19. veebr 2025, 13:30 UTC

Omandamised, ülevõtmised, äriostud

Stryker Completes Acquisition Of Inari Medical, Inc., Providing Entry Into The High-growth Peripheral Vascular Segment >SYK

28. jaan 2025, 21:09 UTC

Omandamised, ülevõtmised, äriostud

Stryker: Transaction Is Expected to Close in the U.S. in 1H 2025 >SYK

28. jaan 2025, 21:09 UTC

Omandamised, ülevõtmised, äriostud

Stryker: Agreement Includes Binding Offer to Acquire Stryker's Spinal Implants Business in France >SYK

28. jaan 2025, 21:08 UTC

Omandamised, ülevõtmised, äriostud

Stryker: After Closing, VB Spine Will Become a Strategic Partner to Stryker With Exclusive Access to Mako Spine and Copilot for Use With VB Spine's Implants in Spine Procedures >SYK

28. jaan 2025, 21:08 UTC

Omandamised, ülevõtmised, äriostud

Stryker: Agreement to Sell U.S. Spinal Implants Business to Viscogliosi Brothers, LLC to Create Newly Formed Co Called VB Spine, LLC >SYK

28. jaan 2025, 21:06 UTC

Tulu

Stryker Sees Organic Net Sales Growth of 8% to 9% for 2025 >SYK

Võrdlus sarnastega

Hinnamuutus

Stryker Corp Prognoos

Hinnasiht

By TipRanks

11.33% tõus

12 kuu keskmine prognoos

Keskmine 435.77 USD  11.33%

Kõrge 456 USD

Madal 407 USD

Põhineb 16 Wall Streeti analüütiku instrumendi Stryker Corp 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Tugev "osta" hinnang

16 ratings

13

Osta

3

Hoia

0

Müü

Tehniline skoor

By Trading Central

373.92 / 383.99Toetus ja vastupanu

Lühikene perspektiiv

Weak Bullish Evidence

Keskpikk perspektiiv

Bullish Evidence

Pikk perspektiiv

Bullish Evidence

Sentiment

By Acuity

111 / 371 Pingereas Tervishoid

Uudiste sentiment

Languse märgid

Volatiilsus

Alla keskmise

Uudismaht (RCV)

Üle keskmise

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest Stryker Corp

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical and thoracolumbar systems that include fixation, minimally invasive and interbody systems used in spinal injury, complex spine and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment, and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, clinical communication and workflow solutions, and other medical device products that are used in various medical specialties, as well as patient and caregiver safety technologies. This segment also provides neurosurgical, neurovascular and craniomaxillofacial implant products, which include products used for minimally invasive endovascular procedures; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke; and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Portage, Michigan.